NASDAQ:CPIX

Cumberland Pharmaceuticals Short Interest Ratio and Short Volume

$2.72
-0.01 (-0.37 %)
(As of 09/23/2021 04:00 PM ET)
Add
Compare
Today's Range
$2.70
$2.77
50-Day Range
$2.72
$3.40
52-Week Range
$2.58
$3.94
Volume15,876 shs
Average Volume40,925 shs
Market Capitalization$40.47 million
P/E RatioN/A
Dividend YieldN/A
Beta0.2

Cumberland Pharmaceuticals (NASDAQ:CPIX) Short Interest Data

Current Short Volume87,700 shares
Previous Short Volume89,700 shares
Change Vs. Previous Month-2.23%
Dollar Volume Sold Short$252,576.00
Short Interest Ratio / Days to Cover3.7
Last Record DateAugust, 31 2021
Outstanding Shares14,880,000 shares
Float Size8,440,000 shares
Short Percent of Float1.04%
Today's Trading Volume15,876 shares
Average Trading Volume40,925 shares
Today's Volume Vs. Average-61.21%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cumberland Pharmaceuticals ?

Sign up to receive the latest short interest report for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Cumberland Pharmaceuticals (NASDAQ:CPIX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202187,700 shares $252,576.00 -2.2%1.0%3.7 $2.88
8/13/202189,700 shares $256,542.00 +4.2%1.1%3.4 $2.86
7/30/202186,100 shares $279,825.00 -3.3%1.0%3.1 $3.25
7/15/202189,000 shares $284,800.00 -18.4%1.0%3.2 $3.20
6/30/2021109,000 shares $310,650.00 +3.4%1.3%3.5 $2.85
6/15/2021105,400 shares $326,740.00 +1.9%1.2%3.7 $3.10
5/28/2021103,400 shares $305,030.00 +2.3%1.2%3.2 $2.95
5/14/2021101,100 shares $269,937.00 +0.8%1.2%2.8 $2.67
4/30/2021100,300 shares $273,819.00 -6.0%1.2%1.7 $2.73
4/15/2021106,700 shares $326,502.00 +5.3%1.3%1.6 $3.06
3/31/2021101,300 shares $314,030.00 -4.9%1.2%1.5 $3.10
3/15/2021106,500 shares $364,230.00 +3.1%1.3%1.6 $3.42
2/26/2021103,300 shares $347,088.00 +2.6%1.2%1.6 $3.36
2/12/2021100,700 shares $331,303.00 +2.0%1.2%1.6 $3.29
1/29/202198,700 shares $312,879.00 -1.8%1.2%2.3 $3.17
1/15/2021100,500 shares $326,625.00 +1.6%1.2%2.7 $3.25
12/31/202098,900 shares $299,667.00 +1.1%1.2%3.5 $3.03
12/15/202097,800 shares $294,378.00 -0.1%1.2%3.8 $3.01
11/30/202097,900 shares $292,721.00 +1.0%1.2%4.5 $2.99
11/15/202096,900 shares $290,700.00 +0.4%1.1%5.4 $3.00
10/30/202096,500 shares $290,465.00 +0.3%1.1%6.5 $3.01
10/15/202096,200 shares $295,334.00 +0.1%1.1%5.6 $3.07
9/30/202096,100 shares $308,481.00 +0.2%1.1%3.3 $3.21
9/15/202095,900 shares $319,347.00 -2.1%1.1%3.4 $3.33
8/31/202098,000 shares $315,560.00 +2.5%1.1%3.3 $3.22

Cumberland Pharmaceuticals (NASDAQ:CPIX) Short Interest FAQ

speech bubbles
speech bubbles











Cumberland Pharmaceuticals (NASDAQ:CPIX) Short Interest Frequently Asked Questions

What is Cumberland Pharmaceuticals' current short interest?

Short interest is the volume of Cumberland Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of August 31st, traders have sold 87,700 shares of CPIX short. 1.04% of Cumberland Pharmaceuticals' shares are currently sold short. Learn More on Cumberland Pharmaceuticals' current short interest.

What is a good short interest ratio for Cumberland Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Cumberland Pharmaceuticals currently has a short interest ratio of 4.0. Learn More on a good short interest ratio for Cumberland Pharmaceuticals

What is a good short interest percentage for Cumberland Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.04% of Cumberland Pharmaceuticals' floating shares are currently sold short.

Is Cumberland Pharmaceuticals' short interest increasing or decreasing?

Cumberland Pharmaceuticals saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 87,700 shares, a decline of 2.2% from the previous total of 89,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cumberland Pharmaceuticals' float size?

Cumberland Pharmaceuticals currently has issued a total of 14,880,000 shares. Some of Cumberland Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cumberland Pharmaceuticals currently has a public float of 8,440,000 shares.

How does Cumberland Pharmaceuticals' short interest compare to its competitors?

1.04% of Cumberland Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "pharmaceuticals" compare to Cumberland Pharmaceuticals: Johnson & Johnson (0.00%), Pfizer Inc. (0.00%), Eli Lilly and Company (0.77%), AbbVie Inc. (0.77%), Merck & Co., Inc. (0.00%), Bristol-Myers Squibb (0.92%), Zoetis Inc. (0.62%), Horizon Therapeutics Public Limited (1.85%), Royalty Pharma plc (1.80%), and Jazz Pharmaceuticals plc (6.23%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short Cumberland Pharmaceuticals stock?

Short selling CPIX is an investing strategy that aims to generate trading profit from Cumberland Pharmaceuticals as its price is falling. Cumberland Pharmaceuticals' stock is trading down $0.01 today. To short Cumberland Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Cumberland Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cumberland Pharmaceuticals?

A short squeeze for Cumberland Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CPIX, which in turn drives the price of the stock up even further.

How often is Cumberland Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CPIX, twice per month. The most recent reporting period available is August, 31 2021.



This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.